Overview

Registry Protocol for Tracking Trial Subjects After VTI-206 Study Completion

Status:
Withdrawn
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
VTI-207 (NCT01452295) is designed to follow subjects, both treated and control, for five years after their completion of study participation in protocol VTI-206 (NCT00973817) to gather information relating to the incidence of liver transplant, the incidence and type of cancer (if any), and survival.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Vital Therapies, Inc.